Sarepta Therapeutics (SRPT) Debt/Equity Ratio: History & Chart

Sarepta Therapeutics, Inc.(SRPT)

Biotechnology · Cambridge, MA

$17.25-0.24 (-1.40%)

Delayed quote: Oct 6, 2026, 2:10 PM EDT

About Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company dedicated to the discovery and advancement of genetic treatment modalities, including RNA-targeted therapeutics and gene therapies, specifically for rare diseases. The company currently offers two approved treatments: EXONDYS 51, prescribed for Duchenne muscular dystrophy (DMD) patients with confirmed dystrophin gene mutations amenable to exon 51 skipping, and VYONDYS 53, for DMD patients with exon 53 skipping mutations. Sarepta's development pipeline includes AMONDYS 45, an exon-skipping product candidate utilizing phosphorodiamidate morpholino oligomer chemistry for exon 45; SRP-5051, a peptide-conjugated PMO designed to target exon 51 of dystrophin pre-mRNA; and gene therapy programs such as SRP-9001 for DMD and SRP-9003 for limb-girdle muscular dystrophies. The company maintains collaborative agreements with organizations like F. Hoffman-La Roche Ltd, Nationwide Children's Hospital, Lysogene, Duke University, Genethon, and StrideBio. Founded in 1980, Sarepta Therapeutics is headquartered in Cambridge, Massachusetts.

Cambridge, MA

835 employees

www.sarepta.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Michael E. Severino

View full financials

SRPT Debt to Equity Ratio Metrics

DEBT TO EQUITY RATIO

0.68

DEBT TO EQUITY RATIO AVG TTM

0.85

DEBT TO EQUITY RATIO AVG 3Y

1.18

DEBT TO EQUITY RATIO AVG 5Y

1.38

DEBT TO EQUITY RATIO AVG 10Y

0.96

DEBT TO EQUITY RATIO AVG 15Y

0.65

DEBT TO EQUITY RATIO AVG 20Y

0.48

CURRENT VS TTM AVG

-19.07%

CURRENT VS 3Y AVG

-42.20%

CURRENT VS 5Y AVG

-50.35%

CURRENT VS 10Y AVG

-28.57%

CURRENT VS 15Y AVG

+5.89%

CURRENT VS 20Y AVG

+41.42%

SECTOR MEDIAN · HEALTHCARE

0.11

median of 766 covered companies

CURRENT VS SECTOR MEDIAN

+522.32%

vs the sector median at left

NAME	MARKET CAP	DEBT TO EQUITY RATIO	TTM	3Y	5Y
Sarepta Therapeutics, Inc. (SRPT)	$1.82B	0.68	0.85	1.18	1.38
LeMaitre Vascular, Inc. (LMAT)vs ›	$1.82B	0.45	0.51	0.29	0.25
Immunome, Inc. (IMNM)vs ›	$1.82B	0.01	0.02	0.02	0.01
Xencor, Inc. (XNCR)vs ›	$1.80B	0.13	0.32	0.21	0.15
Astrana Health, Inc. (ASTH)vs ›	$1.84B	1.18	1.02	0.74	0.70
Azenta, Inc. (AZTA)vs ›	$1.85B	0.04	0.05	0.03	0.05
Novavax, Inc. (NVAX)vs ›	$1.79B	N/A	0.75	0.75	0.38
Generate Biomedicines, Inc. (GENB)vs ›	$1.79B	0.14	N/A	N/A	N/A
Palvella Therapeutics, Inc. (PVLA)vs ›	$1.86B	0.00	0.01	0.01	0.14
Absci Corporation (ABSI)vs ›	$1.78B	0.01	0.04	0.07	0.09

NAME

MARKET CAP

DEBT TO EQUITY RATIO

TTM

Sarepta Therapeutics, Inc. (SRPT)

$1.82B

0.68

0.85

1.18

1.38

LeMaitre Vascular, Inc. (LMAT)vs ›

$1.82B

0.45

0.51

0.29

0.25

Immunome, Inc. (IMNM)vs ›

$1.82B

0.01

0.02

0.01

Xencor, Inc. (XNCR)vs ›

$1.80B

0.13

0.32

0.21

0.15

Astrana Health, Inc. (ASTH)vs ›

$1.84B

1.18

1.02

0.74

0.70

Azenta, Inc. (AZTA)vs ›

$1.85B

0.04

0.05

0.03

0.05

Novavax, Inc. (NVAX)vs ›

$1.79B

N/A

0.75

0.38

Generate Biomedicines, Inc. (GENB)vs ›

$1.79B

0.14

N/A

Palvella Therapeutics, Inc. (PVLA)vs ›

$1.86B

0.00

0.01

0.14

Absci Corporation (ABSI)vs ›

$1.78B

0.01

0.04

0.07

0.09

Debt to Equity Ratio FAQ

What is the debt to equity ratio for Sarepta Therapeutics, Inc. (SRPT)?

The debt to equity ratio for SRPT stock is 0.68.

Is Sarepta Therapeutics, Inc.'s debt to equity ratio high or low?

The debt to equity ratio of 0.68 is 50% below its 5-year average of 1.38, near the low end of its 5-year range (0.68–4.20).

What is the TTM average debt to equity ratio for Sarepta Therapeutics, Inc. (SRPT)?

The TTM average debt to equity ratio for SRPT stock is 0.85.

What is the 3Y average debt to equity ratio for Sarepta Therapeutics, Inc. (SRPT)?

The 3Y average debt to equity ratio for SRPT stock is 1.18.

What is the 5Y average debt to equity ratio for Sarepta Therapeutics, Inc. (SRPT)?

The 5Y average debt to equity ratio for SRPT stock is 1.38.

What is the 10Y average debt to equity ratio for Sarepta Therapeutics, Inc. (SRPT)?

The 10Y average debt to equity ratio for SRPT stock is 0.96.

What is the 15Y average debt to equity ratio for Sarepta Therapeutics, Inc. (SRPT)?

The 15Y average debt to equity ratio for SRPT stock is 0.65.

What is the 20Y average debt to equity ratio for Sarepta Therapeutics, Inc. (SRPT)?

The 20Y average debt to equity ratio for SRPT stock is 0.48.

DATE	DEBT TO EQUITY RATIO
2026-06-30	0.68
2026-03-31	0.69
2025-12-31	0.91
2025-09-30	0.95
2025-06-30	1.00
2025-03-31	1.18
2024-12-31	0.88
2024-09-30	1.14
2024-06-30	1.27
2024-03-31	1.44
2023-12-31	1.63
2023-09-30	1.79
2023-06-30	1.84
2023-03-31	1.81
2022-12-31	4.20
2022-09-30	3.66
2022-06-30	1.57
2022-03-31	1.33
2021-12-31	1.24
2021-09-30	2.47
2021-06-30	2.39
2021-03-31	2.15
2020-12-31	1.44
2020-09-30	0.86
2020-06-30	0.74
2020-03-31	0.66
2019-12-31	0.90
2019-09-30	0.49
2019-06-30	0.44
2019-03-31	0.35
2018-12-31	0.41
2018-09-30	0.65
2018-06-30	0.63
2018-03-31	0.55
2017-12-31	0.55
2017-09-30	0.04
2017-06-30	0.03
2017-03-31	0.03
2016-12-31	0.05
2016-09-30	0.05
2016-06-30	0.17
2016-03-31	0.15
2015-12-31	0.12
2015-09-30	0.19
2015-06-30	0.16
2015-03-31	0.03
2014-12-31	0.03
2014-09-30	0.02
2014-06-30	0.01
2014-03-31	0.01
2013-12-31	0.01
2013-09-30	0.01
2013-06-30	0.02
2013-03-31	0.02
2012-12-31	0.01
2012-09-30	-0.39
2012-06-30	0.08
2012-03-31	0.13
2011-12-31	0.06
2011-09-30	0.06
2011-06-30	0.05
2011-03-31	2.07
2010-12-31	-0.68
2010-09-30	0.47
2010-06-30	0.23
2010-03-31	0.13
2009-12-31	0.08
2009-09-30	0.10
2009-06-30	0.69
2009-03-31	0.11
2008-12-31	0.13
2008-09-30	0.13
2008-06-30	0.10
2008-03-31	0.10
2007-12-31	0.08
2007-09-30	0.14
2007-06-30	0.09
2007-03-31	0.00
2006-12-31	0.00
2006-09-30	0.00
2006-06-30	0.00
2006-03-31	0.00
2005-12-31	0.00
2005-09-30	0.00
2005-06-30	0.00
2005-03-31	0.00
2004-12-31	0.00
2004-09-30	0.00
2004-06-30	0.00
2004-03-31	0.00
2003-12-31	0.00
2003-09-30	0.00
2003-06-30	0.00
2003-03-31	0.00
2002-12-31	0.00
2002-09-30	0.00

DATE

DEBT TO EQUITY RATIO

2026-06-30

0.68

2026-03-31

0.69

2025-12-31

0.91

2025-09-30

0.95

2025-06-30

1.00

2025-03-31

1.18

2024-12-31

0.88

2024-09-30

1.14

2024-06-30

1.27

2024-03-31

1.44

2023-12-31

1.63

2023-09-30

1.79

2023-06-30

1.84

2023-03-31

1.81

2022-12-31

4.20

2022-09-30

3.66

2022-06-30

1.57

2022-03-31

1.33

2021-12-31

1.24

2021-09-30

2.47

2021-06-30

2.39

2021-03-31

2.15

2020-12-31

1.44

2020-09-30

0.86

2020-06-30

0.74

2020-03-31

0.66

2019-12-31

0.90

2019-09-30

0.49

2019-06-30

0.44

2019-03-31

0.35

2018-12-31

0.41

2018-09-30

0.65

2018-06-30

0.63

2018-03-31

0.55

2017-12-31

0.55

2017-09-30

0.04

2017-06-30

0.03

2017-03-31

0.03

2016-12-31

0.05

2016-09-30

0.05

2016-06-30

0.17

2016-03-31

0.15

2015-12-31

0.12

2015-09-30

0.19

2015-06-30

0.16

2015-03-31

0.03

2014-12-31

0.03

2014-09-30

0.02

2014-06-30

0.01

2014-03-31

0.01

2013-12-31

0.01

2013-09-30

0.01

2013-06-30

0.02

2013-03-31

0.02

2012-12-31

0.01

2012-09-30

-0.39

2012-06-30

0.08

2012-03-31

0.13

2011-12-31

0.06

2011-09-30

0.06

2011-06-30

0.05

2011-03-31

2.07

2010-12-31

-0.68

2010-09-30

0.47

2010-06-30

0.23

2010-03-31

0.13

2009-12-31

0.08

2009-09-30

0.10

2009-06-30

0.69

2009-03-31

0.11

2008-12-31

0.13

2008-09-30

0.13

2008-06-30

0.10

2008-03-31

0.10

2007-12-31

0.08

2007-09-30

0.14

2007-06-30

0.09

2007-03-31

0.00

2006-12-31

0.00

2006-09-30

0.00

2006-06-30

0.00

2006-03-31

0.00

2005-12-31

0.00

2005-09-30

0.00

2005-06-30

0.00

2005-03-31

0.00

2004-12-31

0.00

2004-09-30

0.00

2004-06-30

0.00

2004-03-31

0.00

2003-12-31

0.00

2003-09-30

0.00

2003-06-30

0.00

2003-03-31

0.00

2002-12-31

0.00

2002-09-30

0.00

Debt to Equity Ratio: 0.68

SRPT Debt to Equity Ratio

SRPT Average Debt to Equity Ratio Chart

SRPT Current vs Average Debt to Equity Ratio Chart

SRPT Debt to Equity Ratio Metrics

SRPT Competitors' Debt to Equity Ratio

Financial Health

Debt to Equity Ratio Formula & Definition

Debt to Equity Ratio FAQ

SRPT Debt to Equity Ratio History

Related Metrics